Generis acquisition to strengthen ARBP's Europe business Aurobindo Pharma (ARBP) has acquired Generis Farmaceutica SA (Generis) for 135mn (including net working capital of 21.7mn) with reasonable valuation at 2.1x EV/Sales and 10.4x EV/EBITDA. With this acquisition (Generis SA: 2nd largest player by value), combined entity would become the largest player in Portuguese generic pharma market. In CY16, Generis generated 85% of sales from retail (73%) and hospital (12%) segment and have a well-diversified portfolio of 227 products, out of which 51 are pending for approval. Portuguese pharmaceutical market size is estimated at...